Posted by john on July 31st, 2006 — in Paxil Top News
CAFC affirmed a lower court’s invalidation of Apotex’s Paxil patent — finding that its product-by-process claims were invalid because they attempted to recapture the end-product from the public domain. According to that decision, “once a product is fully disclosed in the art, future claims to that same product are precluded, even if that product is […]
No Comments »
Posted by john on July 30th, 2006 — in Paxil Top News
Baum Hedlund filed a lawsuit today against Philadelphia-based GlaxoSmithKline (”GSK”), the maker of Paxil, in Pennsylvania State Court, on behalf of its clients Anthony and Matilda Vasquez of Bedford, Texas, and their son Adrian. The family alleges that Mrs. Vasquez’s ingestion of Paxil during her pregnancy resulted in her son being born with severe heart […]
No Comments »
Posted by john on July 28th, 2006 — in Paxil Top News
Baum Hedlund filed a lawsuit today against Philadelphia-based GlaxoSmithKline (”GSK”), the maker of Paxil, in Pennsylvania State Court, on behalf of its clients Anthony and Matilda Vasquez of Bedford, Texas, and their son Adrian. The family alleges that Mrs. Vasquez’s ingestion of Paxil during her pregnancy resulted in her son being born with severe heart […]
No Comments »
Posted by john on July 24th, 2006 — in Paxil Top News
People taking migraine drugs together with some antidepressants are at risk of a life-threatening condition, U.S. health officials warned Wednesday.
Serotonin syndrome can occur when migraine headache drugs called triptans are taken with antidepressants known as selective serotonin/norepinephrine reuptake inhibitors, or SSRIs and SNRIs. The syndrome occurs when the body has too much of the nervous […]
No Comments »
Posted by john on July 24th, 2006 — in Paxil Top News
People taking migraine drugs together with some antidepressants are at risk of a life-threatening condition, U.S. health officials warned Wednesday.
Serotonin syndrome can occur when migraine headache drugs called triptans are taken with antidepressants known as selective serotonin/norepinephrine reuptake inhibitors, or SSRIs and SNRIs. The syndrome occurs when the body has too much of the nervous […]
No Comments »
Posted by john on July 20th, 2006 — in Paxil Top News
Jury deliberations are expected to begin today in the murder trial of Simon Faeed Ranteesi, a former Vacaville welder arrested in 2002 after his estranged wife, Milia, was bludgeoned to death during an argument outside Ranteesi’s Topaz Circle home.
Following five days of testimony in the Vallejo branch of Solano County Superior Court, prosecution and defense […]
No Comments »
Posted by john on July 17th, 2006 — in Paxil Top News
IT was 5 on a crisp morning, and I had just left my building with Missy, my Welsh springer, for her first walk of the day. We headed along 73rd Street toward West End Avenue, turned right on West End and right again on 74th Street.
A third of the way down the block, we encountered […]
No Comments »
Posted by john on July 12th, 2006 — in Paxil Top News
said Tuesday that it received federal approval to sell the drug Avandamet as an initial therapy for diabetes.
Avandamet was approved in 2002 as a second-line therapy for patients who can’t control their blood-sugar levels with another drug. The company said it now has an adequate supply of the drug, more than 15 months after federal […]
No Comments »
Posted by john on July 11th, 2006 — in Paxil Top News
For pregnant women considering whether to continue taking antidepressant drugs, a study in a February issue of the Journal of the American Medical Association, or JAMA, contained a sobering warning: Stopping the medication greatly increases the risk of relapsing into depression.
The study authors — most of them leading psychiatrists at Massachusetts General Hospital, the University […]
No Comments »
Posted by john on July 7th, 2006 — in Paxil Top News
Doctors and their patients need a more balanced picture of the risks and benefits of the popular antidepressants known as selective serotonin reuptake inhibitors (SSRIs), a new report contends.
Current practices and research methods tend to exaggerate the benefits and underestimate the risks of suicide posed by the drugs, according to an “analysis and comment” published […]
No Comments »